Conceptions Reproductive Associates Inc.

Profile narrative

Conceptions Reproductive Associates Inc. operates as a fertility clinic that provides assisted reproductive technologies and related reproductive health services to individuals and couples seeking to achieve pregnancy. The organisation’s core offerings include in‑vitro fertilisation, intrauterine insemination, ovulation induction, and genetic screening of embryos. It serves patients primarily within the United States, with a notable presence in the state of Colorado where the recent legal proceedings originated. The clinic’s focus is on helping clients overcome infertility through personalized treatment plans and laboratory‑based interventions. Its services are delivered by a team of reproductive endocrinologists, embryologists, and support staff.

The organisation’s scale can be inferred from the 2024 data breach that exposed the personal information of roughly 80,000 patients, indicating a substantial patient base under its care. This figure reflects the number of individuals whose protected health information was compromised in the incident reported on January 1, 2024. The breach prompted a proposed class‑action lawsuit alleging negligence, public disclosure of private facts, breach of implied contract, breach of fiduciary duty, and violations of the Colorado Consumer Protection Act. While the clinic succeeded in having an intrusion‑upon‑seclusion claim dismissed, the court found that the lead plaintiffs adequately pleaded the remaining claims, allowing the case to proceed. The incident highlights the volume of sensitive data the organisation handles as part of its reproductive health operations.

As a specialised provider in the reproductive medicine sector, Conceptions Reproductive Associates Inc. is subject to federal health privacy regulations such as HIPAA and state‑specific statutes governing the confidentiality of fertility‑related data. Its distinguishing attributes include a clinical focus on assisted reproduction, laboratory expertise in embryo culture and genetic testing, and a patient‑centred approach to infertility treatment. The organisation’s positioning within the healthcare market is defined by its niche service line, which differentiates it from general obstetrics‑gynecology practices. Information regarding its ownership structure, parent‑company affiliations, or subsidiary relationships is not explicitly disclosed in the available sources. Consequently, any description of its corporate governance must be limited to the publicly known facts about its operations and the recent legal exposure.

Incidents

1 incident linked to this organisation.